Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Vodafone Group appoints Stephen Carter as a non-executive director
New Report Highlights Key Industry Trends in Pharmaceutical R&DNEW YORK, April 28, 2022, the global business intelligence provider for the biopharma industry, and The American Society of Gene & Cell Therapy.
Investegate announcements from Informa Business Intelligence, Informa Pharma Intelligence and The American Society of Gene & Cell Therapy (ASGCT) Launches Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report